Tags

Type your tag names separated by a space and hit enter

A Randomized, Crossover Trial of a Nutritional Intervention for Rheumatoid Arthritis.
Am J Lifestyle Med. 2025 Feb; 19(2):266-275.AJ

Abstract

To investigate the effects of a dietary intervention on arthritis pain and disease severity, 44 adults previously diagnosed with rheumatoid arthritis were randomly assigned to a Diet phase (vegan diet for 4 weeks, elimination of additional foods for 3 weeks, and then reintroduction of the eliminated foods individually over 9 weeks) or a Supplement (placebo) phase for 16 weeks. After a 4-week washout, they then switched to the opposite phase. The Disease Activity Score-28 (DAS28) decreased from 4.5 to 2.5 (P < .001) in the Diet phase and from 3.2 to 2.9 (P = .41) in the Supplement phase (between-group P = .01). The mean number of swollen joints decreased from 7.0 to 3.3 in the Diet phase (P = .03) and increased from 4.7 to 5 in the Supplement phase (P = .63; between-group P = .047). In a subanalysis excluding individuals who increased medications during the study, DAS28 decreased 1.9 points in the Diet phase (P = .003) and .4 points in the Supplement phase (P = .27; between-group P = .04). In a further subanalysis limited to participants making no medication changes, DAS28 decreased 1.5 points in the Diet phase (P = .009) and .3 points in the Supplement phase (P = .40, between-group P = .11). We conclude that the dietary intervention was associated with symptomatic improvements. TRIAL REGISTRATION: Clinicaltrials.gov NCT01544101, NCT01700881, NCT03417648, and NCT03580681.

Authors+Show Affiliations

George Washington University School of Medicine & Health Science; Physicians Committee for Responsible Medicine, Washington, DC, USA.Physicians Committee for Responsible Medicine, Washington, DC, USA.Physicians Committee for Responsible Medicine, Washington, DC, USA.Physicians Committee for Responsible Medicine, Washington, DC, USA.School of Medicine, University of Utah, Salt Lake City, UT, USA.Physicians Committee for Responsible Medicine, Washington, DC, USA.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

39981557

Citation

Barnard, Neal D., et al. "A Randomized, Crossover Trial of a Nutritional Intervention for Rheumatoid Arthritis." American Journal of Lifestyle Medicine, vol. 19, no. 2, 2025, pp. 266-275.
Barnard ND, Levin S, Crosby L, et al. A Randomized, Crossover Trial of a Nutritional Intervention for Rheumatoid Arthritis. Am J Lifestyle Med. 2025;19(2):266-275.
Barnard, N. D., Levin, S., Crosby, L., Flores, R., Holubkov, R., & Kahleova, H. (2025). A Randomized, Crossover Trial of a Nutritional Intervention for Rheumatoid Arthritis. American Journal of Lifestyle Medicine, 19(2), 266-275. https://doi.org/10.1177/15598276221081819
Barnard ND, et al. A Randomized, Crossover Trial of a Nutritional Intervention for Rheumatoid Arthritis. Am J Lifestyle Med. 2025;19(2):266-275. PubMed PMID: 39981557.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - A Randomized, Crossover Trial of a Nutritional Intervention for Rheumatoid Arthritis. AU - Barnard,Neal D, AU - Levin,Susan, AU - Crosby,Lee, AU - Flores,Rosendo, AU - Holubkov,Richard, AU - Kahleova,Hana, Y1 - 2022/04/03/ PY - 2022/4/3/medline PY - 2022/4/3/pubmed PY - 2025/2/21/entrez PY - 2023/4/3/pmc-release KW - Arthritis KW - diet KW - joint pain KW - nutrition KW - plant-based KW - vegan SP - 266 EP - 275 JF - American journal of lifestyle medicine JO - Am J Lifestyle Med VL - 19 IS - 2 N2 - To investigate the effects of a dietary intervention on arthritis pain and disease severity, 44 adults previously diagnosed with rheumatoid arthritis were randomly assigned to a Diet phase (vegan diet for 4 weeks, elimination of additional foods for 3 weeks, and then reintroduction of the eliminated foods individually over 9 weeks) or a Supplement (placebo) phase for 16 weeks. After a 4-week washout, they then switched to the opposite phase. The Disease Activity Score-28 (DAS28) decreased from 4.5 to 2.5 (P < .001) in the Diet phase and from 3.2 to 2.9 (P = .41) in the Supplement phase (between-group P = .01). The mean number of swollen joints decreased from 7.0 to 3.3 in the Diet phase (P = .03) and increased from 4.7 to 5 in the Supplement phase (P = .63; between-group P = .047). In a subanalysis excluding individuals who increased medications during the study, DAS28 decreased 1.9 points in the Diet phase (P = .003) and .4 points in the Supplement phase (P = .27; between-group P = .04). In a further subanalysis limited to participants making no medication changes, DAS28 decreased 1.5 points in the Diet phase (P = .009) and .3 points in the Supplement phase (P = .40, between-group P = .11). We conclude that the dietary intervention was associated with symptomatic improvements. TRIAL REGISTRATION: Clinicaltrials.gov NCT01544101, NCT01700881, NCT03417648, and NCT03580681. SN - 1559-8284 UR - https://www.unboundmedicine.com/medline/citation/39981557/full_citation DB - PRIME DP - Unbound Medicine ER -